Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
Background: Glioblastoma multiforme (GBM) is the most malignant type of glioma. GBM tumors grow rapidly, have a high degree of malignancy, and are characterized by a fast disease progression. Unfortunately, there is a lack of effective treatments. An effective strategy for the treatment of GBM would...
| 發表在: | Translational Oncology |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Elsevier
2023-10-01
|
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S1936523323001250 |
